Close Menu
Journal of Pharmacology and Pharmacotherapeutics
    Browse
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Facebook X (Twitter) Instagram
    Journal of Pharmacology and PharmacotherapeuticsJournal of Pharmacology and Pharmacotherapeutics
    • Journal Homepage (SAGE)
    • Submission Guidelines
    Facebook X (Twitter) Instagram
    Submit
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Past Issues
    • About
      • About Journal
      • Editorial Board
      • Bibliographic Listings
    • For Authors
      • Submission Guidelines
      • Submit Article
    • Contact
    Journal of Pharmacology and Pharmacotherapeutics
    Home»Uncategorized»Evaluation of Topical Lifitegrast Formulations for Treatment of Psoriasis
    Uncategorized

    Evaluation of Topical Lifitegrast Formulations for Treatment of Psoriasis

    April 18, 20251 Min Read
    Share
    Facebook Twitter Email

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
    BackgroundLifitegrast, a lymphocyte function-associated antigen-1 antagonist, was found to be useful in the treatment of psoriasis.PurposeThe study aimed to evaluate semisolid formulations of lifitegrast for their physicochemical and efficacy performance….

    Read Original Source

    Previous ArticleComparative Study of In Vitro Anti-proliferative Activity of Metformin, Teneligliptin, and Canagliflozin Against Breast Cancer Cell Line
    Next Article A Comparative Study of Reno-protection with Combination of N-acetylcysteine and Keto Analogs Versus Probiotics and Keto Analogs in Predialytic Chronic Kidney Disease

    Related Articles

    Prospective Risk Management in the Process of Clinical Studies in the Republic of Serbia

    Uncategorized

    Early Whole Bowel Irrigation to Treat Colchicine Overdose: A Brief Review of 30 Years of Decontamination Strategies

    Uncategorized

    Innovative Pharmacotherapeutic Strategies for Autoimmune and Inflammatory Disorders: Advancing Precision Medicine in Disease Management

    Uncategorized
    Read Now
    Uncategorized

    Prospective Risk Management in the Process of Clinical Studies in the Republic of Serbia

    January 7, 2026

    Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundIn Serbia, as well as worldwide, clinical…

    Early Whole Bowel Irrigation to Treat Colchicine Overdose: A Brief Review of 30 Years of Decontamination Strategies

    January 2, 2026

    Innovative Pharmacotherapeutic Strategies for Autoimmune and Inflammatory Disorders: Advancing Precision Medicine in Disease Management

    December 31, 2025
    Editor picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    About Journal
    About Journal

    The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer-reviewed journal that publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics.

    We're accepting new partnerships right now.

    Email Us: editor.jpp@phcog.net

    Facebook X (Twitter) RSS
    Our Picks

    WITHDRAWN – Administrative Duplicate Publication: ML-powered Internet of Medical Things Structure for Heart Disease Prediction

    February 18, 2025

    Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and Its Mutated Variants: Challenges and Future Directions

    February 18, 2025

    Low Back Pain Management Through Bowel Lavage (Panchaprasrutik Basti)—A Single Arm Clinical Trial

    February 18, 2025
    Stay Connected

    Contact Editor-In-Chief
    Editor, Journal of Pharmacology and Pharmacotherapeutics
    Manuscript TechnoMedia LLP,
    #9, Vinnse Tower, Wheeler Road Extn.
    St. Thomas Town, 560084, Bangalore, INDIA
    Email: editor.jpp@phcog.net


    • Home
    • Site Map
    © 2026 JPharmacol.com Designed & Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.